These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Certain characteristics of the action of intestinal hormones in diseases of the digestive organs]. Geller LI; Glinskaia TP; Kazimirchuk AP; Murzina NB; Ozherel'eva NIa Klin Med (Mosk); 1976 Oct; 54(10):63-8. PubMed ID: 1011728 [No Abstract] [Full Text] [Related]
4. [Secretin as a possible therapeutic agent in ulcer disease]. Geller LI; Glinskaia TP; Kozlova ZP Vrach Delo; 1974 Dec; (12):55-8. PubMed ID: 4446534 [No Abstract] [Full Text] [Related]
5. [Secretin treatment of patients with postoperative dumping syndrome (dyshormonal digestive asthenia)]. Rafes IuI; Kornilova SN Klin Khir (1962); 1976 Nov; (11):69-71. PubMed ID: 1003750 [No Abstract] [Full Text] [Related]
6. [Treatment of duodenal ulcer with synthetic depot secretin - a double-blind study]. Scholten T; Fritsch WP; Hagenmüller F; Classen M; Knop P; Hausamen TU; Lingenberg G; Portocarrero G; Safrany L; Seifert E; Zeus U; Stadelmann O Z Gastroenterol; 1983 May; 21(5):212-9. PubMed ID: 6349151 [TBL] [Abstract][Full Text] [Related]
7. Treatment of duodenal ulcer with secretin: a speculative proposal. Grossman MI Gastroenterology; 1966 Jun; 50(6):912-3. PubMed ID: 5212382 [No Abstract] [Full Text] [Related]
8. A trial of exogenous secretin in the treatment of duodenal ulcer pain. Höj L; Holst JJ; Rune SJ Scand J Gastroenterol; 1973; 8(3):279-81. PubMed ID: 4724928 [No Abstract] [Full Text] [Related]
9. [Therapeutic use of secretin in the postoperative dumping syndrome]. Rafes IuS; Mel'nichenko LIa Sov Med; 1983; (3):95-7. PubMed ID: 6857382 [No Abstract] [Full Text] [Related]
10. [Clinical effects of "Secrepan", a secretin preparation, on duodenal ulcer]. Ishikawa M; Kataoka S; Ueno T; Takahashi T; Goto T Horumon To Rinsho; 1979 Jan; 27(1):115-20. PubMed ID: 428120 [No Abstract] [Full Text] [Related]
11. [Effect of gastrozepin on the rate of gastric emptying in patients with peptic ulcer and dumping syndrome following gastric resection]. Saakian Ag Klin Med (Mosk); 1985 Apr; 63(4):72-6. PubMed ID: 2863418 [No Abstract] [Full Text] [Related]
12. [Changes of the exocrine pancreatic function and results of secretin therapy in duodenal ulcer]. Brailski VC; Mendisova A; Dimitrov B Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):245-7. PubMed ID: 1021403 [No Abstract] [Full Text] [Related]
13. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment. Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of gastric and duodenal ulcer. Conservative treatment of the ulcer diseases]. Demling L Chirurg; 1968 Nov; 39(11):485-8. PubMed ID: 5704014 [No Abstract] [Full Text] [Related]
15. [Clinical use of secretin in chronic pancreatitis]. Bogdanovich EA Vrach Delo; 1978 Nov; (11):39-43. PubMed ID: 726401 [No Abstract] [Full Text] [Related]
16. The influence of pentagastrin and secretin on the PH in duodenum. Demling L; Kock H; Classen M Acta Hepatogastroenterol (Stuttg); 1972 Jun; 19(3):186-9. PubMed ID: 4600200 [No Abstract] [Full Text] [Related]
17. [Secretin and peptic ulcer]. Malov IuS Ter Arkh; 1985; 57(2):6-9. PubMed ID: 4002139 [TBL] [Abstract][Full Text] [Related]
18. The treatment of chronic recurrent pancreatitis with depot secretin--a preliminary report. Tympner F; Rösch W Hepatogastroenterology; 1986 Aug; 33(4):159-62. PubMed ID: 2428719 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics of secretin incretion in diseases of the digestive organs]. Geller LI; Glinskaia TP; Petrenko VF Ter Arkh; 1977; 49(10):102-6. PubMed ID: 594890 [No Abstract] [Full Text] [Related]